| Type 1 n = 1265 | Type 2 n = 3845 | |||
| OR (95% CI) | p Value | OR (95% CI) | p Value | |
| White European vs South Asian | 0.86 (0.46 to 1.60) | 0.638 | 1.60 (1.22 to 2.10) | <0.001 |
| Age <59 vs ≥60 | 1.10 (0.65 to 1.86) | 0.721 | 1.63 (1.28 to 2.07) | <0.001 |
| Females vs males | 2.10 (1.39 to 3.19) | <0.001 | 1.48 (1.19 to 1.84) | <0.001 |
| Comorbidities vs none | 1.89 (1.21 to 2.96) | 0.005 | 1.53 (1.22 to 1.92) | <0.001 |
| Complications vs none | 1.84 (1.11 to 3.04) | 0.018 | 1.33 (1.04 to 1.71) | 0.023 |
| Insulin yes vs no | – | – | 1.53 (1.17 to 2.00) | 0.001 |
| OAD yes vs no | – | – | 1.06 (0.82 to 1.36) | 0.664 |
| BMI* (5 unit change) | 1.02 (0.97 to 1.06) | 0.454 | 1.01 (0.99 to 1.03) | 0.121 |
| HbA1c (1 unit change) | 1.05 (0.93 to 1.17) | 0.411 | 1.00 (0.94 to 1.07) | 0.879 |
| Duration of diabetes | ||||
| 6–14 vs 0–5 | 0.65 (0.33 to 1.26) | 0.203 | 1.16 (0.88 to 1.53) | 0.299 |
| 15+ vs 0–5 | 0.58 (0.31 to 1.11) | 0.104 | 0.99 (0.71 to 1.38) | 0.942 |
| IMDS | ||||
| 2 vs 1 | 0.92 (0.53 to 1.62) | 0.796 | 1.30 (0.94 to 1.81) | 0.117 |
| 3 vs 1 | 0.71 (0.63 to 1.95) | 0.710 | 1.55 (1.11 to 2.15) | 0.009 |
| 4 vs 1 | 1.08 (0.59 to 1.96) | 0.794 | 1.49 (1.09 to 2.07) | 0.013 |
*Including imputed data.BMI, body mass index; CI, confidence interval; HbA1c, glycosylated haemoglobin; IMDS, indices of multiple deprivation score; OAD, oral anti-diabetic drug; OR, odds ratio.